Cancer BiologybioRxivPreprint
Systematic functional drug testing in patient-derived models reveals ex vivo sensitivities associated with clinical outcome in rare solid tumors
Jasmina Paluncic, Zunamys Itzell Carrero, Lilly KS Fischer…·Claudia R. Ball
This study develops an ex vivo drug sensitivity testing platform for rare solid tumors and finds that high in vitro sensitivity correlates with clinical benefit and progression-free survival.
1 citation